| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2010 | WO2009099596A4 Macrocyclic serine protease inhibitors |
| 02/04/2010 | WO2009019260A3 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage |
| 02/04/2010 | WO2009001129A9 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 02/04/2010 | WO2008153374A8 Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent |
| 02/04/2010 | WO2008132710A3 Pharmaceutical nimodipine compositions |
| 02/04/2010 | WO2008121859A8 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
| 02/04/2010 | WO2007018687A8 Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| 02/04/2010 | WO2003076575A9 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 02/04/2010 | US20100029950 Novel substituted 1h-dihydropyrazoles, their preparation and use |
| 02/04/2010 | US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 02/04/2010 | US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/04/2010 | US20100029897 Anion-binding polymers and uses thereof |
| 02/04/2010 | US20100029783 Stabilized compositions of alkylating agents and methods of using same |
| 02/04/2010 | US20100029782 Calcilytic Compounds |
| 02/04/2010 | US20100029781 Methods for preparation of anti-acne formulation and compositions prepared thereby |
| 02/04/2010 | US20100029780 Topical composition |
| 02/04/2010 | US20100029779 Composition and method for treatment of mrsa |
| 02/04/2010 | US20100029778 Hair and/or scalp treatment compositions |
| 02/04/2010 | US20100029777 4-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof |
| 02/04/2010 | US20100029775 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 02/04/2010 | US20100029774 Aliskiren monofumarate and processes for preparation thereof |
| 02/04/2010 | US20100029773 Systematic identification of new anti-prion drugs by high-throughput screening based on scanning for intensely fluorescent targets (sift) |
| 02/04/2010 | US20100029772 Dicarboxylic Acid Derivatives and their Use |
| 02/04/2010 | US20100029771 Treatment of addictive disorders |
| 02/04/2010 | US20100029770 Methods of treating mental retardation, down's syndrome, fragile X syndrome and autism |
| 02/04/2010 | US20100029769 N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, sodium lauryl sulfoacetate as penetration enhancers incorporated in a topical formulation to facilitate administration of diclofenac for topical or transdermal therapy or cosmetic use |
| 02/04/2010 | US20100029768 Compositions and Methods For Promoting Fat Loss |
| 02/04/2010 | US20100029767 Anthranilic acid derivatives |
| 02/04/2010 | US20100029766 Blends Comprising a Substituted Fatty Acid or a Derivative Thereof |
| 02/04/2010 | US20100029765 Topical aqueous composition comprising tretinoin |
| 02/04/2010 | US20100029764 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |
| 02/04/2010 | US20100029763 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses |
| 02/04/2010 | US20100029762 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
| 02/04/2010 | US20100029761 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 02/04/2010 | US20100029760 Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity |
| 02/04/2010 | US20100029759 Composition useful for the treatment of type 2 diabetes |
| 02/04/2010 | US20100029758 Derivatives of isoflavones |
| 02/04/2010 | US20100029757 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases |
| 02/04/2010 | US20100029756 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture |
| 02/04/2010 | US20100029755 P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 02/04/2010 | US20100029754 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 02/04/2010 | US20100029753 Modulators of ccr9 receptor and methods of use thereof |
| 02/04/2010 | US20100029752 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 02/04/2010 | US20100029751 Compositions comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis |
| 02/04/2010 | US20100029750 Novel crosslinked pei nanoparticle based transfection agents for delivery of biomolecules |
| 02/04/2010 | US20100029749 Chimeric NK Receptor and Methods for Treating Cancer |
| 02/04/2010 | US20100029748 Metastasis Promoting Genes and Proteins |
| 02/04/2010 | US20100029747 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 02/04/2010 | US20100029745 Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use |
| 02/04/2010 | US20100029744 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
| 02/04/2010 | US20100029743 Atorvastatin pharmaceutical compositions |
| 02/04/2010 | US20100029742 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/04/2010 | US20100029741 Fused heterocycles |
| 02/04/2010 | US20100029740 Azabicyclic compounds as serotonin, dopamine and norepinephrine re-uptake inhibitors |
| 02/04/2010 | US20100029739 Use of a combination of hypothermia inducing drugs |
| 02/04/2010 | US20100029738 Bicyclic Tetrahydropyrrole Compounds |
| 02/04/2010 | US20100029737 Inhibitors of d-amino acid oxidase |
| 02/04/2010 | US20100029736 2-substituted proline bis-amide orexin receptor antagonists |
| 02/04/2010 | US20100029735 Therapeutic compounds |
| 02/04/2010 | US20100029734 Methods for breast cancer screening and treatment |
| 02/04/2010 | US20100029733 Bicyclic nitrogen-containing heterocyclic compounds |
| 02/04/2010 | US20100029732 Combinations of Beta-2-Adrenoceptor Agonistic Benzothiazolone |
| 02/04/2010 | US20100029731 Method for preparing largazole analogs and uses thereof |
| 02/04/2010 | US20100029729 Compounds |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029727 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 02/04/2010 | US20100029726 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 02/04/2010 | US20100029724 Screening method |
| 02/04/2010 | US20100029723 Methods and compositions for reduction of side effects of therapeutic treatments |
| 02/04/2010 | US20100029722 Organic compounds |
| 02/04/2010 | US20100029721 Pharmaceutical Formulation Comprising Metformin and Repaglinide |
| 02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029718 Organic compounds |
| 02/04/2010 | US20100029717 Alkylsulphonamide Quinolines |
| 02/04/2010 | US20100029716 Novel 1,2,3,4- tetrahydroquinoline derivatives |
| 02/04/2010 | US20100029715 Polymorphic forms of a macrocyclic inhibitor of hcv |
| 02/04/2010 | US20100029714 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 02/04/2010 | US20100029713 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
| 02/04/2010 | US20100029712 Irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 02/04/2010 | US20100029711 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/04/2010 | US20100029710 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029708 Compounds and compositions for treatment of cancer |
| 02/04/2010 | US20100029707 Tricyclic compound and medical use thereof |
| 02/04/2010 | US20100029706 HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029704 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 02/04/2010 | US20100029703 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 02/04/2010 | US20100029702 Method For Identification of Compound Having Anti-Anxiety Effect |
| 02/04/2010 | US20100029701 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/04/2010 | US20100029700 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors |
| 02/04/2010 | US20100029699 Matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029697 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 02/04/2010 | US20100029696 Indolylamino quinazoline derivatives as antitumor agents |
| 02/04/2010 | US20100029695 Method of treating dermatitis comprising administering a chymase inhibitor |
| 02/04/2010 | US20100029694 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/04/2010 | US20100029693 Novel pi3k delta inhibitors and methods of use thereof |
| 02/04/2010 | US20100029692 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 02/04/2010 | US20100029691 Fast onset orodispersable tablets |